PBM lobby goes on the offensive
Summary
The main pharmacy benefit manager (PBM) lobbying group in the U.S. has increased its efforts to influence lawmakers. This move comes after Congress approved new rules changing how PBMs operate, following years of blame from drug companies about high medicine prices.Key Facts
- The top PBM lobbying group is actively advocating for its industry.
- Congress passed a law last winter that changes PBM regulations.
- Pharmaceutical companies had blamed PBMs for raising drug prices.
- PBMs manage prescription drug benefits for health plans and negotiate prices.
- The new law aims to overhaul the PBM business to address drug cost concerns.
- The PBM lobby is responding to challenges from both Congress and drug makers.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.